-
Natural Compounds Against SARS-CoV-2: Docking Evidence
2026-09-01
Eskandari’s 2022 study combined virtual screening, molecular docking, and molecular dynamics to evaluate vitamin-derived compounds against SARS-CoV-2 3CLpro and the spike receptor-binding domain. The results nominate several low-cost repurposing candidates, while also illustrating why computational binding predictions require biochemical, biophysical, and infection-model validation before supporting antiviral therapeutics research.
-
Valemetostat: Dual EZH1/2 Inhibition in ATL
2026-09-01
The reference paper explains why Valemetostat, also known as DS-3201, became the first approved dual EZH1/2 inhibitor for aggressive adult T-cell leukemia/lymphoma in Japan. Its central insight is that concurrent EZH1 and EZH2 blockade may overcome compensatory PRC2 activity, while early clinical evidence supports further investigation in relapsed or refractory disease.
-
4μ8C: Selective IRE1 RNase Inhibitor
2026-08-31
4μ8C, also known as 7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde, selectively inhibits IRE1α RNase signaling in cellular ER-stress models. The compound is useful for mechanistic cancer research, but its reported lack of cytotoxic sensitization and unfavorable pharmacokinetics limit interpretation and in vivo use.
-
Plerixafor (AMD3100): A CXCR4 Translation Playbook
2026-08-31
Plerixafor (AMD3100) is more than a CXCR4 pathway reagent: it is a practical mechanistic probe for connecting CXCL12-dependent tumor trafficking, hematopoietic stem cell mobilization, and immune-cell redistribution. This thought-leadership guide shows how translational researchers can use the compound as a benchmark while interpreting emerging CXCR4 inhibitors with appropriate biological and experimental caution.
-
Telatinib: From Kinase Signals to Phenotype
2026-08-30
Telatinib (BAY 57-9352) enables network-level studies of angiogenesis, invasion, and tumor-cell signaling. This guide shows how to distinguish VEGFR-driven effects from c-Kit and PDGFR contributions when translating breast cancer findings into rigorous assays.
-
LTI6426 Enhances Panobinostat in Multiple Myeloma
2026-08-29
This 2022 study identifies the protein disulfide isomerase inhibitor LTI6426 as a preclinical partner for low-dose panobinostat in multiple myeloma, including a proteasome-inhibitor-resistant model. Its central contribution is the mechanistic and pharmacodynamic link to ER-stress effectors ATF3, DDIT3/CHOP, and DNAJB1, which may help guide combination optimization and response monitoring.
-
Bergenin Reprograms γδT17 Cells in Psoriasis
2026-08-28
A 2026 Phytomedicine study identifies a PPARγ–PROX1 ubiquitination pathway through which bergenin suppresses pathogenic γδT17-cell activity and IL-17A production in psoriasis models. Its combination of immune-cell targeting, metabolic analysis, protein-interaction assays, and chromatin profiling provides a mechanistic framework for evaluating plant-derived anti-inflammatory compounds.
-
2X Taq PCR Master Mix for Spatial PCR
2026-08-28
Use 2X Taq PCR Master Mix (with dye) to turn spatial insect-pathogen sampling into a practical, direct-to-gel endpoint PCR workflow. Its ready-to-use format supports genotyping, fungal detection, and TA cloning while reducing pipetting and loading steps.
-
Erastin Workflows for Reproducible Ferroptosis Research
2026-08-27
Erastin is a practical ferroptosis inducer for connecting RAS/BRAF genotype, cystine restriction, glutathione loss, and oxidative cell damage in tumor models. This guide turns the compound into a reproducible workflow, with preparation parameters, orthogonal readouts, cross-domain context from plant ferroptosis research, and troubleshooting for inconsistent responses.
-
Digoxin Workflows for Cardiac and Antiviral Research
2026-08-27
Digoxin is a versatile Na+/K+ ATPase pump inhibitor for linking ion-transport biology with cardiac contractility and cell-type-specific antiviral assays. This workflow-focused guide covers concentration design, controls, cross-domain interpretation, and troubleshooting for more reproducible results.
-
Angiotensin 1/2 (1-6) in Applied Research
2026-08-26
Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, provides a defined tool for renin-angiotensin system research, vascular tone modulation, and receptor-binding assays. Its short sequence also enables comparative studies linking cardiovascular regulation to emerging spike–receptor interaction biology without treating an in vitro finding as clinical evidence.
-
QNZ (EVP4593) Workflow for NF-κB Studies
2026-08-26
QNZ (EVP4593) combines nanomolar NF-κB pathway inhibition with practical applications in inflammatory signaling, reporter assays, and Huntington’s disease research. This workflow connects luciferase, TNF-α, calcium-entry, and chemical-profiling strategies while emphasizing solubility, controls, and interpretation limits.
-
Laminin (925-933): From ECM Signal to Assay Strategy
2026-08-25
Laminin (925-933) is more than a compact adhesion ligand: it is a defined way to separate laminin-receptor signaling from the architectural complexity of full extracellular matrices. This article connects its adhesion and chemotaxis evidence with collagen-VI-enriched iPSC islet organoid research, outlining practical controls, translational opportunities, and the limits of extending peptide data into engineered tissue systems.
-
Sodium Dicloxacillin Monohydrate: Assay Strategy
2026-08-25
Sodium dicloxacillin monohydrate is more than a conventional MSSA antibiotic control: it is a tool for separating compartment, exposure, and endpoint effects in infection research. This guide converts intra- and extracellular pharmacodynamic evidence into a practical assay-design framework.
-
Fangchinoline Restores TFEB Antiviral Lysosomal Defense
2026-08-24
The reference study identifies fangchinoline as a lysosome-targeted inhibitor of H1N1 infection that restores TFEB-dependent lysosomal gene expression, alters lysosomal pH, and obstructs viral entry. Its combined Connectivity Map, transcriptomic, imaging, and functional infection analyses provide a host-directed framework for studying influenza control through lysosomal biology.